Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells $12,039.84 in Stock
MarketBeat
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) CFO Keith A. Goldan sold 1,296 shares of the stock in a transaction dated Wednesday, July 16th. The stock was sold at an average price of $9.29, for a total value of $12,039.84. Following the sale, the chief financial officer owned 92,450 shares of the company's stock, valued at approximately $858,860.50. The trade was a 1.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
NASDAQ:SNDX